Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Demonstrators protest Big Pharma

Demonstrators protest pharmaceutical companies' lobbying outside Pharmaceutical Research and Manufacturers of America (PhRMA) headquarters in Washington, D.C. on September 21, 2021. (Photo: Saul Loeb/AFP via Getty Images)

Big Pharma Has Spent $147 Million to Kill Lower Drug Prices During Pandemic

"The big drug companies spend so massively lobbying to keep the market rigged in their favor and seniors at their mercy, including many literally choosing between food and medicine," said Accountable.US.

Jake Johnson

New research published Wednesday shows that since the coronavirus pandemic began more than two years ago, the five largest pharmaceutical companies in the United States have spent nearly $150 million lobbying against Democratic proposals to lower the country's increasingly outlandish drug prices.

"Big Pharma, like many other industries, knows they cannot justify raising prices so high at the same time they boast of excessive profits."

The analysis by the corporate and government watchdog group Accountable.US estimates that Johnson & Johnson, Eli Lilly, Pfizer, AbbVie, and Merck poured a combined $147.3 million into lobbying Congress since 2020.

"Meanwhile, major pharmaceutical CEOs raked in over $292.6 million" as "their companies saw skyrocketing profits," the report notes.

"Big Pharma, like many other industries, knows they cannot justify raising prices so high at the same time they boast of excessive profits, generous CEO bonuses, and huge shareholder payouts," said Accountable.US spokesperson Liz Zelnick. "That is why the big drug companies spend so massively lobbying to keep the market rigged in their favor and seniors at their mercy, including many literally choosing between food and medicine."

"It is time the conservatives in Congress who complain constantly about inflation finally do something constructive about it—and there's no better place to start than allowing Medicare to finally negotiate lower drug prices," Zelnick added. "What really matters most to these lawmakers: bringing down costs for seniors, or looking out for the bottom line of their big drug company donors?"

The fresh research on Big Pharma's influence-peddling comes as Senate Democrats are working toward a compromise proposal that would allow Medicare to negotiate the prices of a small subset of prescription medicines directly with drug firms that have been pushing up costs with abandon for years.

In 2021, according to one recent study, nearly 18 million U.S. adults couldn't afford at least one medication prescribed by their doctor.

In its current form, the new Democratic plan would cap Medicare Part D enrollees' out-of-pocket prescription drug costs at $2,000 annually, penalize pharmaceutical companies that raise prices at a faster rate than inflation, and require Medicare to negotiate the prices of a limited number of drugs.

The Congressional Budget Office projects the measure would save the U.S.—which spends far more on prescription drugs than other wealthy nations—$290 billion over 10 years.

Unsurprisingly, Pharmaceutical Research and Manufacturers of America (PhRMA)—the drug industry's trade group—has denounced the proposal, decrying its "sweeping government price-setting policies."

Last year, Big Pharma spent heavily to weaken an earlier Democratic drug pricing plan that was ultimately scrapped thanks in large part to Sen. Joe Manchin (D-W.Va.).

While it's despised by the pharmaceutical industry—whose lobbyists on Capitol Hill outnumber members of Congress—the idea of allowing Medicare to directly negotiate drug prices is broadly popular with the U.S. public, garnering more than 80% support across party lines in some polling.

"Giving Medicare the power to negotiate lower drug prices is popular, necessary, and will save lives," the progressive advocacy group Social Security Works said Wednesday. "Now it's time for Democrats in Congress to deliver for us."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

Advocates Applaud as FTC Sues to Stop Microsoft-Activsion Mega-Merger

Biden's FTC, said one consumer campaigner, "is showing, once again, that it is serious about enforcing the law, reversing corporate concentration, and taking on the tough cases."

Brett Wilkins ·


Press Freedom Champions Renew Call for DOJ to Drop Charges Against Assange

"It is time for the Biden administration to break from the Trump administration's decision to indict Assange—a move that was hostile to the media and democracy itself."

Jessica Corbett ·


Oral Arguments Boost Fears of SCOTUS Buying Theory That Would 'Sow Elections Chaos'

"This reckless case out of North Carolina could explode the unifying understanding that power ultimately rests with the people of this country," one campaigner said of Moore v. Harper.

Jessica Corbett ·


War Industry 'Celebrating Christmas Early' as House Passes $858 Billion NDAA

"There is no justification to throw... $858 billion at the Pentagon when we're told we can't afford child tax credit expansion, universal paid leave, or other basic human necessities," said the consumer advocacy group Public Citizen. "End of story."

Brett Wilkins ·


GOP Florida Lawmaker Behind 'Don't Say Gay' Law Charged with Covid Relief Fraud

"It does not surprise me that someone who exploits queer kids for political gain would be charged with exploiting taxpayers for personal gain," said one Democratic state lawmaker.

Julia Conley ·

Common Dreams Logo